These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8854045)

  • 1. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Farmaco; 1997 Mar; 52(3):173-8. PubMed ID: 9212451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
    Jiang Q; Sun CS
    Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
    Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
    J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
    Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
    Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
    Sotelo E; Fraiz N; Yáñez M; Terrades V; Laguna R; Cano E; Raviña E
    Bioorg Med Chem; 2002 Sep; 10(9):2873-82. PubMed ID: 12110307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activity.
    Azzolina O; Dal Piaz V; Collina S; Giovannoni MP; Tadini C
    Chirality; 1997; 9(7):681-5. PubMed ID: 9366028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
    Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
    Pinna GA; Loriga M; Curzu MM; D'Amico M
    Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
    Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1574-7. PubMed ID: 12499593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
    Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
    Coelho A; Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
    Bioorg Med Chem Lett; 2004 Jan; 14(2):321-4. PubMed ID: 14698150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
    Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Brea J; Raviña E
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1575-7. PubMed ID: 12039565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones].
    Xu P; Wang SY; Chen Y; Liu WQ; Tao C
    Yao Xue Xue Bao; 1991; 26(9):656-60. PubMed ID: 1821084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor.
    Coudert P; Rubat C; Couquelet J; Tronche P
    J Pharm Belg; 1990; 45(3):191-5. PubMed ID: 2401951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.
    Costantino L; Rastelli G; Gamberini MC; Giovannoni MP; Dal Piaz V; Vianello P; Barlocco D
    J Med Chem; 1999 Jun; 42(11):1894-900. PubMed ID: 10354397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of 5,6-dihydrobenzo[f] cinnolin-2(3H)ones analogues of antihypertensive and antiaggregating benzo[h]cinnolinones.
    Pinna GA; Curzu MM; Fraghì P; Gavini E; D'Amico M
    Farmaco; 1996 Oct; 51(10):653-8. PubMed ID: 8981755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.